Once the policy framework is in place, an important question will be how additional drugs may be added to the benefit over time. This session will include a focused discussion on the Local Coverage Determination (LCD) reconsideration process, including how stakeholders can request coverage for new therapies, the evidentiary standards Medicare Administrative Contractors (MACs) may apply, and the timelines and procedural steps involved.